Treatment with rhG-CSF for osteomyelitis in a patient with p47-phox-deficient chronic granulomatous disease

Annals of Hematology

Volumn 75, Issue 5-6, 1997, Pages 243-246

  Isotani, H ^a   Fukumoto, Y ^a   Kawamura, H ^a   Sasada, M ^b   Hattori, K ^c   Fujiwara, T ^c   Kobayashi, Y ^c  

^a Hirakata Municipal Hospital   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic granulomatous disease; G CSF; Osteomyelitis; p47 phox deficiency; Superoxide anion (O2 )

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; OSTEOMYELITIS; PRIORITY JOURNAL;

ADULT; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; NADPH OXIDASE; OSTEOMYELITIS; PHOSPHOPROTEINS; RECOMBINANT PROTEINS;

EID: 0030721583     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050351     Document Type: Article

References (17)

1. Curnutte JT, Babior BM (1986) Chronic granulomatous disease, a heterogenous syndrome. Adv Hum Genet 19:229-297
2. Kobayashi Y, Amano D, Ueda K, Kagosaki Y, Usui T (1978) Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim(SMX-TMP). Eur J Pediatr 127:247-254
3. Iwata M, Nunoi H, Yamazaki H, Nakano T, Niwa H, Tsuruta S, Ohga S, Ohmi S, Kanegasaki S, Matsuda I (1994) Homologous dinucleotide (GT or TG) deletion in japanese patients with chronic granulomatous disease with p47-phox deficiency. Biochem Biophys Res Commun 199:1372-1377
4. Sasada M, Yamamoto K, Kubo A (1983) Microbicidal mechanism of neutrophils. Acta Hematol Jpn 46:114-120
5. Ambruso DR, Sasada M, Nishiyama H, Kubo A, Komiyama A. Allen RH (1984) Deffective bactericidal activity and absence of specific granules in neutrophils from a patient. J Clin Immunol 4:23-30
6. Nelson RD, Quie PG, Simmons RL (1975) Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 115:1650-1656
7. 558 of human neutrophils: immunocytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease and their carrier mothers. Blood 69:1404-1408
8. Newburger PE, Chovariec ME, Cohen HJ (1980) Activity and activation of the granulocyte superoxide-generating system. Blood 55:85-92
9. Hayakawa H, Kobayashi N, Yata J (1985) Chronic granulomatous disease in Japan: a summary of the clinical features of 84 registered patients. Acta Paediatr Jpn 27:501-510
10. The international chronic granulomatous disease cooperative study group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324:509-516
11. Kitagawa S, Yuo A, Souza LM, Saito M, Miura Y, Takaku F (1987) Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun 144:1143-1146
12. Ohsaka A, Kitagawa S, Sakamoto S, Miura Y, Takanashi N, Takaku F, Saito M (1989) In vivo activation of human neutrophil functions by administration of human granulocyte colony-stimulating factor in patient with malignant lymphoma. Blood 74:2743-2748
13. Yuo A, Kitagawa S, Kasahara T, Matsushima K, Saito M, Takaku F (1991) Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood 78:2708-2714
14. Fukuda T, Kitagawa S, Azuma E, Yuo A, Kawamata N, Miki T, Hirosawa S, Aoki N (1995) Treatment with granulocyte colony-stimulating factor for pneumonia in a patient with a variant form of X-linked chronic granulomatous disease. Eur J Haematol 55:63-64
15. Jendrossek V, Ritzel A, Neubauer B, Heyden S, Gahr M (1997) An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity. Eur J Haematol 58:78-85
16. Liese JG, Jendrossek V, Jansson A, Petropoulou Th, Kloos S, Gahr M, Belohradsky BH (1995) Chronic granulomatous disease in adults. Lancet 346:220-223
17. Vowells SJ, Fleisher TA, Sekhsaria S, Alling DW, Maguire TE, Malech HL (1996) Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr 128:104-107